Metoprolol Succinate in pharma franchise in Karnataka

Metoprolol Succinate in PCD pharma franchise in Kohima

Metoprolol Succinate in top pharma company in Jaipur

Metoprolol Succinate in pcd pharma supplier in Thane

Metoprolol Succinate in phama franchise company in india
Metoprolol Succinate in phama distributor in Kolkata

Home/Products /metoprolol-succinate-prolonged-release-100-mg-tablet

About the Product

Description


Metoperil XL 100 Tablet is a prolonged-release formulation containing Metoprolol Succinate 100 mg, a cardio-selective beta-1 adrenergic receptor blocker. It is widely prescribed for the management of high blood pressure (hypertension), angina pectoris (chronic chest pain), heart failure, and for preventing cardiovascular complications such as heart attacks and strokes. The 100 mg strength is typically recommended for patients requiring more intensive blood pressure and heart rate control.

Metoprolol works by selectively blocking beta-1 receptors in the heart, which reduces the heart rate, the force of contraction, and overall cardiac output. These effects lead to decreased oxygen demand by the heart and improved efficiency of cardiac function, making it especially useful in patients with ischemic heart conditions or weakened heart muscles.

The prolonged-release (PR) technology in Metoperil XL 100 ensures a steady and controlled release of the drug throughout the day, maintaining consistent blood levels and reducing the frequency of dosing. This not only enhances patient compliance but also minimizes the risk of fluctuations in blood pressure and heart rate.

Metoperil XL 100 is often part of a long-term treatment regimen for patients with chronic cardiovascular conditions, including post-myocardial infarction care, left ventricular dysfunction, and hypertensive heart disease. It may also be used off-label in certain cases such as migraine prophylaxis or arrhythmia management, depending on clinical judgment.

Patients prescribed this medication are advised to maintain a heart-healthy lifestyle alongside medication use. This includes reducing salt intake, managing body weight, avoiding smoking or alcohol, and following a regular exercise routine as advised by the physician.

Metoperil XL 100 is usually well tolerated; however, like all medications, it may cause side effects in some individuals. It should only be used under medical supervision, especially in patients with respiratory conditions, diabetes, or severe circulation disorders.

Common side effects include dizziness, tiredness, slow heart rate, and cold extremities.

Used for the treatment of hypertension, angina, and heart failure; also helps reduce the risk of heart attacks.

Do not stop taking this medicine suddenly without consulting your doctor, as it may worsen heart conditions.

Store in a cool, dry place below 30°C. Protect from light and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Metoprolol Succinate 100 mg PR Tablets in the PCD pharma franchise market?

Metoprolol Succinate 100 mg PR (Prolonged Release) Tablets have strong demand in the cardiology and chronic care segment, making them a valuable prescription product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for hypertension, chronic stable angina, heart failure, arrhythmias, and long-term cardiovascular risk management, ensuring consistent repeat prescription demand.

Why should medical distributors include Metoprolol Succinate 100 mg PR Tablets in their product range?

Medical distributors and agencies benefit from the growing prevalence of cardiovascular diseases requiring long-term therapy. Helps effectively control high blood pressure Supports treatment of chronic stable angina Used in heart failure management under physician supervision Helps manage certain cardiac rhythm disorders (arrhythmias) Prolonged-release formulation provides 24-hour therapeutic coverage with once-daily dosing Widely prescribed by cardiologists and general physicians Strong demand in hospital, clinic, and retail pharmacy segments This makes it a high-demand chronic cardiovascular care product with excellent repeat prescription potential.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metoprolol Succinate 100 mg PR Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and franchise partners benefit from consistent cardiology prescription demand, long-term patient adherence, strong physician confidence, and stable year-round turnover in the cardiovascular segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete cardiology and antihypertensive product portfolio access to build a strong presence in the cardiovascular healthcare market.